Evolent Health, Inc. Quarterly Cost of Revenue in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Evolent Health, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2022 to Q3 2024.
  • Evolent Health, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $541M, a 39.9% increase year-over-year.
  • Evolent Health, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $2.07B, a 53.6% increase year-over-year.
  • Evolent Health, Inc. annual Cost of Revenue for 2023 was $1.5B, a 45.2% increase from 2022.
  • Evolent Health, Inc. annual Cost of Revenue for 2022 was $1.04B, a 57.5% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.07B $541M +$154M +39.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.92B $540M +$188M +53.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $1.73B $536M +$225M +72.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $1.5B $454M +$155M +51.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $1.35B $387M +$120M +45% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $1.23B $352M +$102M +40.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $1.13B $310M +$90.7M +41.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.04B $299M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $267M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $250M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $220M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.